By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301


SEARCH JOBS


Industry
Biotechnology


Collaborations

Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.





Company News
Argos Therapeutics, Inc. (ARGS) Breaks Ground On State-Of-The-Art Biomanufacturing Facility In Research Triangle Park Area 10/22/2014 10:46:10 AM
Argos Therapeutics, Inc. (ARGS) To Hire 236 Staffers For $57 Million North Carolina Facility 10/3/2014 10:08:02 AM
Argos Therapeutics, Inc. (ARGS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/1/2014 9:00:36 AM
Argos Therapeutics, Inc. (ARGS) Enters Into $25 Million Venture Loan Facility Led By Horizon Technology Finance 9/30/2014 8:25:13 AM
Argos Therapeutics, Inc. (ARGS) To Present At The 21st Annual Biocentury Newsmakers Conference 9/19/2014 7:20:27 AM
Enrollment In Argos Therapeutics, Inc. (ARGS)' Pivotal Phase 3 ADAPT Trial Of AGS-003 For Metastatic Renal Cell Carcinoma Surpasses Fifty Percent 9/18/2014 7:40:31 AM
Argos Therapeutics, Inc. (ARGS) Announces Issuance Of Arcelis® Technology Platform Patent 9/8/2014 10:12:10 AM
Argos Therapeutics, Inc. (ARGS) To Present At The Rodman & Renshaw 16th Annual Global Investment Conference 9/3/2014 7:50:34 AM
Argos Therapeutics, Inc. (ARGS) Commits To New Headquarters In Durham 8/25/2014 7:29:16 AM
Argos Therapeutics, Inc. (ARGS) Reports Second Quarter 2014 Financial Results And Operational Highlights 8/13/2014 4:00:01 PM
12345678910...
//-->